CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Cabaletta Bio

For profitWebsite ↗

Also known as: Cabaletta Bio

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2026

Timeline

2010s

Jun 1, 2017
Cabaletta Bio— Founded

Drugs by trial phase (6 distinct, 7 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Pemphigus

Recent trials (14)

NCT07006805Lead sponsorPhase 1/Phase 2Jun 30, 2026
NCT07006805OfficialPhase 1/Phase 2Jun 30, 2026
NCT06359041OfficialPhase 1/Phase 2Oct 31, 2024
NCT06359041Lead sponsorPhase 1/Phase 2Oct 31, 2024
NCT06328777OfficialPhase 1/Phase 2Jul 2, 2024
NCT06328777Lead sponsorPhase 1/Phase 2Jul 2, 2024
NCT06154252Lead sponsorPhase 1/Phase 2Nov 17, 2023
NCT06154252Study chairPhase 1/Phase 2Nov 17, 2023
NCT06121297Lead sponsorPhase 1/Phase 2Oct 13, 2023
NCT06121297Study chairPhase 1/Phase 2Oct 13, 2023
NCT05451212Lead sponsorPhase 1Dec 31, 2022
NCT05451212Study chairPhase 1Dec 31, 2022
NCT04422912Study chairPhase 1Sep 30, 2020
NCT04422912Lead sponsorPhase 1Sep 30, 2020

Details

Founded: Philadelphia, PA, US Jun 1, 2017
Last known activity: Jun 30, 2026